Cargando…

Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact

BACKGROUND: In 2020, an international expert panel proposed a new definition of fatty liver: Metabolic dysfunction-associated fatty liver disease (MAFLD). The MAFLD added the criteria for defining metabolic dysfunctions, which are high-risk factors for liver-related and cardiovascular events. Contra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Si-Ying, Tan, Jian Shiun, Pang, Xian-Zheng, Lee, Guan-Huei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Systematic Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850940/ https://www.ncbi.nlm.nih.gov/pubmed/36688021 http://dx.doi.org/10.3748/wjg.v29.i3.549

Ejemplares similares

Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review
por: Tan, Eunice Xiang-Xuan, et al.
Publicado: (2020)

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
por: Yeh, Ming-Lun, et al.
Publicado: (2023)

Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
por: Yoon, Eileen Laurel, et al.
Publicado: (2023)

Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate
por: Fouad, Yasser
Publicado: (2023)

Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes
por: Alomari, Mohammad, et al.
Publicado: (2023)

Influence of Altered Thyroid Hormone Mechanisms in the Progression of Metabolic Dysfunction Associated with Fatty Liver Disease (MAFLD): A Systematic Review
por: Marschner, Rafael Aguiar, et al.
Publicado: (2022)

Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis
por: Su, Jia-Yong, et al.
Publicado: (2023)

Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

The Diagnostic and Prognostic Value of the Triglyceride-Glucose Index in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Systematic Review and Meta-Analysis
por: Wang, Jing, et al.
Publicado: (2022)

Revised Nomenclature for Fatty Liver Disease: Cutting through the Confusion
por: Alsawat, Khalid, et al.
Publicado: (2020)

Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran
por: Moghaddasifar, I., et al.
Publicado: (2016)

The metabolic associated fatty liver disease responses of lifestyle changes using diet and exercise
por: Altaf, Benash, et al.
Publicado: (2023)

Association of Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease with COVID-19-Related Intensive Care Unit Outcomes: A Systematic Review and Meta-Analysis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

A multisociety Delphi consensus statement on new fatty liver disease nomenclature
por: Rinella, Mary E., et al.
Publicado: (2023)

Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC
por: Liu, Lei, et al.
Publicado: (2022)

Clinical guidelines of non-alcoholic fatty liver disease: A systematic review
por: Zhu, Jin-Zhou, et al.
Publicado: (2016)

The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Biciusca, Teodora, et al.
Publicado: (2023)

Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
por: Lee, Jung Il
Publicado: (2022)

Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population
por: Lee, Guan Huei, et al.
Publicado: (2020)

Embracing the principles of practice transfer to get the word out on the new metabolic dysfunction-associated steatotic liver disease nomenclature
por: Carr, Rotonya M.
Publicado: (2023)

Chinese medicine formulas for nonalcoholic fatty liver disease: Overview of systematic reviews
por: Dai, Liang, et al.
Publicado: (2021)

Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis
por: Dajani, Asad Izziddin, et al.
Publicado: (2020)

Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
por: Lai, Jiaming, et al.
Publicado: (2023)

Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease - A Systematic Review and Meta-Analysis
por: Lee, Shi-Yan, et al.
Publicado: (2022)

Effect of Nut Consumption on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Pan, Ling, et al.
Publicado: (2023)

Waiting for Multi-Stakeholders̕ Consensus Position Statement on New Nonalcoholic Fatty Liver Disease Nomenclature
por: Yoon, Eileen L., et al.
Publicado: (2022)

Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease
por: Xiao, Yuji, et al.
Publicado: (2023)

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
por: Han, A Lum
Publicado: (2022)

Association of food intake with a risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study
por: Huang, Xian-Hua, et al.
Publicado: (2023)

Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
por: Miao, Lei, et al.
Publicado: (2022)

Dietary Sodium and Nonalcoholic Fatty Liver Disease: A Systematic Review
por: da Silva Ferreira, Guilherme, et al.
Publicado: (2023)

Liver cirrhosis and left ventricle diastolic dysfunction: Systematic review
por: Stundiene, Ieva, et al.
Publicado: (2019)

The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease
por: Forlano, Roberta, et al.
Publicado: (2022)

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2021)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Association between non-alcoholic fatty liver disease and obstructive sleep apnea
por: Umbro, Ilaria, et al.
Publicado: (2020)

Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update
por: Alharthi, Jawaher, et al.
Publicado: (2022)

Therapeutic developments in metabolic dysfunction-associated fatty liver disease
por: Shi, Yiwen, et al.
Publicado: (2022)

Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
por: Perdomo, Carolina M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_evmqvr2sq90ck935pnqb4c6gsc